Jake R. Morgan, PhD
Research Assistant Professor
Boston University School of Public Health
Health Law, Policy & Management

PhD, Boston University
MS, Montana State University
BS, Hillsdale College



Jake Morgan, PhD, is a health services researcher specializing in using real-world data to inform evidence-based policy, update clinical guidelines, and improve patient access to and quality of care.

His work is focused on the opioid overdose epidemic and how to best support patients by promoting access and retention to medications for opioid use disorder. His work on the comparative effectiveness of medications for opioid use disorder has been cited in a call for research by the director of the National Institute on Drug Abuse Nora Volkow and he has a history of collaboration with Massachusetts Department of Public Health to evaluate and inform addiction treatment services. His work has consistently reinforced the importance of patient choice when it comes to treatment for opioid use disorder and has documented the effects of policies that usurp this choice through onerous requirements for treatment, restricting access to vulnerable populations such as individuals who are incarcerated, and cost-sharing schemes that disincentivize treatment. As an applied health economist with extensive experience in statistical, econometric, and simulation modeling approaches, Dr. Morgan frequently works alongside clinical researchers to highlight (and cost) the best treatment interventions for patients. He is currently involved with the Health Economics core of the The HEALing Communities Study; the Prevention and Rescue Of Fentanyl and Other Opioid Overdoses Using Optimized Naloxone Distribution Strategies (PROFOUND) study; the Researching Effective Strategies to Prevent Opioid Death (RESPOND) simulation model, and; The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for HCV trial.

Dr. Morgan works closely with The Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH) as a member of the Population Data and Modeling Core and is the primary representative for Boston University School of Public Health. The Center’s mission is to develop and disseminate health economic research on healthcare utilization, health outcomes, and health-related behaviors to inform policy to improve care for individuals with substance use disorder, HIV, and HCV. To that end, CHERISH offers resources and consultations to support this type of research for trainees and investigators at any stage. Please see https://cherishresearch.org/ or contact Dr. Morgan to learn more.


Researching Effective Strategies to Prevent Opioid Death (RESPOND)
09/15/2023 - 07/31/2028 (Multi-PI)
PI: Jake R. Morgan, PhD
Boston Medical Center Corporation NIH NIDA
5R01DA046527-08

Health Economics of Substance Use Disorder, HCV, and HIV Treatment: Evaluating Intervention Outcomes for Individuals, Systems, and Communities
07/15/2020 - 04/30/2026 (Subcontract PI)
Weill Medical College of Cornell University NIH NIDA
5P30DA040500-10

Assessing and Addressing Inequities in Cardiovascular Health of Transgender and Gender Diverse Persons
07/01/2022 - 06/30/2025 (Subcontract PI)
Boston Medical Center Corporation Doris Duke Fdn


Justice Community Overdose Innovation Network (JCOIN) - Phase II Coordination and Translation Center
09/01/2024 - 05/31/2025 (Subcontract PI)
George Mason University NIH NIDA
2U2CDA050097-06

Evaluation of a persuasive health communication intervention designed to increase HIV/HCV screening
09/30/2022 - 03/31/2025 (Subcontract PI)
Icahn School of Medicine at Mount Sinai NIH NIDA
5R01DA055533-03

Assessing the burden of dementia in transgender populations.
06/15/2024 - 03/21/2025 (Subcontract PI)
Boston Medical Center Corporation NIH NHLBI
3K01HL151902-04S1

JCOIN Coordination and Translation Center Yr 4 – Rapid Response
07/01/2023 - 08/31/2024 (Subcontract PI)
George Mason University NIH NIDA
5U2CDA050097-04

Researching Effective Strategies to Prevent Opioid Death (RESPOND)
04/01/2019 - 03/31/2024 (Subcontract PI)
Boston Medical Center Corporation NIH NIDA
5R01DA046527-05

Prevention and Rescue Of Fentanyl and Other Opioid Overdoses Using Optimized Naloxone Distribution Strategies (PROFOUND)
05/15/2019 - 02/29/2024 (Subcontract PI)
Weill Medical College of Cornell NIH NIDA
5U01DA047408-05

IMPROVING NALOXONE ACCESS AND ITS EFFECTS ON DRUG ABUSE AND OVERDOSES
02/25/2019 - 08/31/2023 (Subcontract PI)
RAND Corporation HHS CDC
5R01CE002999-02

Showing 10 of 18 results. Show All Results


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Friedmann PD, Wilson D, Stopka TJ, Bernson D, Pivovarova E, Ferguson W, Hoskinson RA, Rottapel RE, Bovell-Ammon B, Gaba A, Morgan JR, Senst T, Hayes E, Evans EA. Medications for Opioid Use Disorder in County Jails - Outcomes after Release. N Engl J Med. 2025 Sep 11; 393(10):994-1003. PMID: 40929634; DOI: 10.1056/NEJMsa2415987;
     
  2. Haukoos J, Rothman RE, Galbraith JW, Hopkins E, Hsieh YH, Lyle C, Gravitz S, Kamis KF, White DAE, Lyons MS, Gardner EM, Al-Tayyib AA, Sabel AL, Linas BP, Morgan JR, Wyles DL, Rowan SE. Hepatitis C Screening in Emergency Departments: The DETECT Hep C Randomized Clinical Trial. JAMA. 2025 Aug 12; 334(6):497-507.View Related Profiles. PMID: 40632510; PMCID: PMC12242825; DOI: 10.1001/jama.2025.10563;
     
  3. Brown JL, Larochelle MR, Fanucchi LC, Calvert DC, Campbell ANC, Chandler RK, Feaster DJ, Glasgow LM, Gibson EB, Holloway J, Lofwall MR, Mack A, Mack N, Nunes EV, Talbert JC, Tan S, Vandergrift N, Villani J, Asman K, Babakhanlou-Chase H, Bagley SM, Battaglia TA, Blevins D, Bridden C, Cheng DM, Christopher M, Cogan LW, Cunningham CO, Eggleston B, Fareed N, Fernandez S, Freedman DA, Freiermuth CE, Freisthler B, Gilbert L, Hammerslag L, Harris D, Hunt T, Hussain S, Huynh P, Jackson RD, Kauffman EB, Knott C, Knudsen HK, Lefebvre RC, Levin FR, Massatti R, McAlearney AS, Morgan JR, Lopez RM, Lounsbury DW, Newman L, Nickels K, Oga EA, Oller DA, Parran TV, Quinn M, Ramsey KS, Rapkin BD, Salsberry P, Stein M, Taylor JL, Teater J, Walters ST, Zarkin GA, El-Bassel N, Winhusen TJ, Samet JH, Walsh SL. Effects of the Communities That HEAL intervention on initiation, retention, and linkage to medications for opioid use disorder (MOUD): A cluster randomized wait-list controlled trial. Drug Alcohol Depend. 2025 Sep 01; 274:112785.View Related Profiles. PMID: 40684522; PMCID: PMC12302724; DOI: 10.1016/j.drugalcdep.2025.112785;
     
  4. Levengood TW, Shaw LC, Zang X, Schackman BR, Walley AY, Urquhart C, Green TC, Chatterjee A, Marshall BDL, Morgan JR. A geospatial analysis of naloxone distribution patterns in the Massachusetts overdose education and naloxone distribution program (MA OEND). Drug Alcohol Depend. 2025 Sep 01; 274:112783.View Related Profiles. PMID: 40683013; PMCID: PMC12439111; DOI: 10.1016/j.drugalcdep.2025.112783;
     
  5. Morgan JR, Walley AY. You have to be alive to enjoy the porridge: The role of Goldilocks naloxone dosing in a world of hungry bears. Addiction. 2025 Nov; 120(11):2175-2176.View Related Profiles. PMID: 40458977
     
  6. Zwick H, O'Dea R, Barocas JA, Flam-Ross JM, Chatterjee A, Walley AY, Harris RA, Schackman BR, White LF, Chrysanthopoulou SA, Assoumou SA, Murphy SM, Morgan JR, Baptiste D, Carroll M, Linas BP. Health and Economic Outcomes of Addressing Encampments of Individuals Using Opioids. JAMA Netw Open. 2025 Jun 02; 8(6):e2517095.View Related Profiles. PMID: 40577017; PMCID: PMC12205401; DOI: 10.1001/jamanetworkopen.2025.17095;
     
  7. Lee CS, Cordova-Ramos EG, Rohsenow DJ, Mueser KT, Pace CA, Martin R, Colby SM, Lopez V, Morris M, Morgan JR, Kriegsman A, Drainoni ML. Care management staff perspectives on stigma and barriers to substance use treatment experienced by latine adults who use substances. Drug Alcohol Depend Rep. 2025 Jun; 15:100342.View Related Profiles. PMID: 40495911; PMCID: PMC12148818; DOI: 10.1016/j.dadr.2025.100342;
     
  8. Assoumou SA, Morgan JR. A Path Forward for Extended-Release Buprenorphine-Optimizing Implementation Strategies. JAMA Netw Open. 2025 May 01; 8(5):e2513010.View Related Profiles. PMID: 40445626
     
  9. Fry CE, Jeffery AD, Horta M, Li Y, Osmundson SS, Phillippi J, Schirle L, Morgan JR, Leech AA. Changes in Postpartum Opioid Prescribing After Implementation of State Opioid Prescribing Limits. JAMA Health Forum. 2024 Nov 01; 5(11):e244216. PMID: 39602107; PMCID: PMC11787902; DOI: 10.1001/jamahealthforum.2024.4216;
     
  10. Zang X, Skinner A, Li Z, Shaw LC, Behrends CN, Chatterjee A, Jalali A, Jordan AE, Morgan JR, Nolen S, Schackman BR, Marshall BDL, Walley AY. Improving racial/ethnic health equity and naloxone access among people at risk for opioid overdose: A simulation modeling analysis of community-based naloxone distribution strategies in Massachusetts, United States. Addiction. 2025 Feb; 120(2):316-326.View Related Profiles. PMID: 39450522; PMCID: PMC11707306; DOI: 10.1111/add.16691;
     
Showing 10 of 81 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 81 publications over 12 distinct years, with a maximum of 13 publications in 2022

YearPublications
20141
20156
20164
20173
20185
20196
20206
202110
202213
202311
20248
20258

Note: X.com has changed/limited the ability to embed tweets directly in external sites and we are investigating ways to restore that functionality in BU Profiles. In the meantime we are displaying a link to your x.com profile in the Websites section above.

2016 Patient-Centered Outcomes Research Institute (PCORI): Trainee Scholarship
2015 Lee Lusted Prize winner
Contact for Mentoring:
Morgan's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department